Purdue affiliate in China pushes misleading opioid claims
Hello, everyone, and nice to see you again after a brief sojourn in a foreign land, where we had a chance to hobnob with some interesting and well-informed people. Now, though, we have returned to the usual routine. Time does go quickly, yes? So once again, we are firing up the trusty coffee kettle for a cup of stimulation (maple pecan is truly delicious) and scavenging for items of interest. On that note, here are a few tidbits to get you going. Hope today is a productive one and you conquer the world.
Even as Purdue Pharma fights lawsuits accusing the company of using misleading tactics to promote highly addictive opioids, another company owned by the Sackler family has used the same tactics to peddle its signature painkiller, OxyContin, in China, the Associated Press reports. Mundipharma tells doctors that time-release painkillers like OxyContin are less addictive than other opioids — the same pitch that Purdue Pharma, the U.S. company owned by the family, admitted was false in court more than a decade ago.